 | • レポートコード：QY2207C3869 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のディオスメクタイトの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にディオスメクタイトの世界市場のxxx％を占める「成人用医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「細菌性下痢」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のディオスメクタイトの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのディオスメクタイト市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのディオスメクタイト市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ディオスメクタイトのグローバル主要メーカーには、Simcere、Ipson、Yangtze River Pharmaceutical Group、Shangdong Hongjitang Pharmaceutical、Conba Pharmaceutical、Harbin Pharmaceutical Group、Luye Pharma Group、ZhuZhou QianJin Pharmaceutical、Zhejiang Hailisheng Pharmaceutical、Hanmi Pharmaceutical、Lukang Pharmaceutical、China Resources Double-crane Pharmaceutical、Honz Pharmaceutical、Siromed、Salvat、Bliss GVS Pharma、Weiao Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ディオスメクタイト市場は、種類と用途によって区分されます。世界のディオスメクタイト市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 成人用医薬品、小児用医薬品、動物用医薬品 【用途別セグメント】 細菌性下痢、ウイルス性下痢、口腔炎症、食道炎、胃炎 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ディオスメクタイト製品概要 - 種類別市場（成人用医薬品、小児用医薬品、動物用医薬品） - 用途別市場（細菌性下痢、ウイルス性下痢、口腔炎症、食道炎、胃炎） - 調査の目的 ・エグゼクティブサマリー - 世界のディオスメクタイト販売量予測2017-2028 - 世界のディオスメクタイト売上予測2017-2028 - ディオスメクタイトの地域別販売量 - ディオスメクタイトの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ディオスメクタイト販売量 - 主要メーカー別ディオスメクタイト売上 - 主要メーカー別ディオスメクタイト価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（成人用医薬品、小児用医薬品、動物用医薬品） - ディオスメクタイトの種類別販売量 - ディオスメクタイトの種類別売上 - ディオスメクタイトの種類別価格 ・用途別市場規模（細菌性下痢、ウイルス性下痢、口腔炎症、食道炎、胃炎） - ディオスメクタイトの用途別販売量 - ディオスメクタイトの用途別売上 - ディオスメクタイトの用途別価格 ・北米市場 - 北米のディオスメクタイト市場規模（種類別、用途別） - 主要国別のディオスメクタイト市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのディオスメクタイト市場規模（種類別、用途別） - 主要国別のディオスメクタイト市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のディオスメクタイト市場規模（種類別、用途別） - 主要国別のディオスメクタイト市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のディオスメクタイト市場規模（種類別、用途別） - 主要国別のディオスメクタイト市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのディオスメクタイト市場規模（種類別、用途別） - 主要国別のディオスメクタイト市場規模（トルコ、サウジアラビア） ・企業情報 Simcere、Ipson、Yangtze River Pharmaceutical Group、Shangdong Hongjitang Pharmaceutical、Conba Pharmaceutical、Harbin Pharmaceutical Group、Luye Pharma Group、ZhuZhou QianJin Pharmaceutical、Zhejiang Hailisheng Pharmaceutical、Hanmi Pharmaceutical、Lukang Pharmaceutical、China Resources Double-crane Pharmaceutical、Honz Pharmaceutical、Siromed、Salvat、Bliss GVS Pharma、Weiao Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ディオスメクタイトの産業チェーン分析 - ディオスメクタイトの原材料 - ディオスメクタイトの生産プロセス - ディオスメクタイトの販売及びマーケティング - ディオスメクタイトの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ディオスメクタイトの産業動向 - ディオスメクタイトのマーケットドライバー - ディオスメクタイトの課題 - ディオスメクタイトの阻害要因 ・主な調査結果 |
Diosmectite (brand names Smecta, Smecdral) is a natural silicate of aluminium and magnesium used as an intestinal adsorbent in the treatment of several gastrointestinal diseases, including infectious and non-infectious acute and chronic diarrhoea, including irritable bowel syndrome diarrhea subtype. Other uses include: chronic diarrhea caused by radiation-induced, chemotherapy-induced, and HIV/AIDS-associated chronic diarrhea.
Market Analysis and Insights: Global Diosmectite Market
Due to the COVID-19 pandemic, the global Diosmectite market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Adult Medication accounting for % of the Diosmectite global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Bacterial Diarrhea segment is altered to an % CAGR throughout this forecast period.
China Diosmectite market size is valued at US$ million in 2021, while the US and Europe Diosmectite are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diosmectite landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Diosmectite include Simcere, Ipson, Yangtze River Pharmaceutical Group, Shangdong Hongjitang Pharmaceutical, Conba Pharmaceutical, Harbin Pharmaceutical Group, Luye Pharma Group, ZhuZhou QianJin Pharmaceutical and Zhejiang Hailisheng Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Diosmectite Scope and Segment
Diosmectite market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diosmectite market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Adult Medication
Children’s Medication
Veterinary Drug
Segment by Application
Bacterial Diarrhea
Viral Diarrhea
Oral Inflammation
Esophagitis
Gastritis
By Company
Simcere
Ipson
Yangtze River Pharmaceutical Group
Shangdong Hongjitang Pharmaceutical
Conba Pharmaceutical
Harbin Pharmaceutical Group
Luye Pharma Group
ZhuZhou QianJin Pharmaceutical
Zhejiang Hailisheng Pharmaceutical
Hanmi Pharmaceutical
Lukang Pharmaceutical
China Resources Double-crane Pharmaceutical
Honz Pharmaceutical
Siromed
Salvat
Bliss GVS Pharma
Weiao Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Diosmectite Product Introduction
1.2 Market by Type
1.2.1 Global Diosmectite Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adult Medication
1.2.3 Children’s Medication
1.2.4 Veterinary Drug
1.3 Market by Application
1.3.1 Global Diosmectite Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bacterial Diarrhea
1.3.3 Viral Diarrhea
1.3.4 Oral Inflammation
1.3.5 Esophagitis
1.3.6 Gastritis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diosmectite Sales Estimates and Forecasts 2017-2028
2.2 Global Diosmectite Revenue Estimates and Forecasts 2017-2028
2.3 Global Diosmectite Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diosmectite Sales by Region
2.4.1 Global Diosmectite Sales by Region (2017-2022)
2.4.2 Global Sales Diosmectite by Region (2023-2028)
2.5 Global Diosmectite Revenue by Region
2.5.1 Global Diosmectite Revenue by Region (2017-2022)
2.5.2 Global Diosmectite Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diosmectite Sales by Manufacturers
3.1.1 Global Top Diosmectite Manufacturers by Sales (2017-2022)
3.1.2 Global Diosmectite Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diosmectite in 2021
3.2 Global Diosmectite Revenue by Manufacturers
3.2.1 Global Diosmectite Revenue by Manufacturers (2017-2022)
3.2.2 Global Diosmectite Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diosmectite Revenue in 2021
3.3 Global Diosmectite Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diosmectite Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diosmectite Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diosmectite Sales by Type
4.1.1 Global Diosmectite Historical Sales by Type (2017-2022)
4.1.2 Global Diosmectite Forecasted Sales by Type (2023-2028)
4.1.3 Global Diosmectite Sales Market Share by Type (2017-2028)
4.2 Global Diosmectite Revenue by Type
4.2.1 Global Diosmectite Historical Revenue by Type (2017-2022)
4.2.2 Global Diosmectite Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diosmectite Revenue Market Share by Type (2017-2028)
4.3 Global Diosmectite Price by Type
4.3.1 Global Diosmectite Price by Type (2017-2022)
4.3.2 Global Diosmectite Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diosmectite Sales by Application
5.1.1 Global Diosmectite Historical Sales by Application (2017-2022)
5.1.2 Global Diosmectite Forecasted Sales by Application (2023-2028)
5.1.3 Global Diosmectite Sales Market Share by Application (2017-2028)
5.2 Global Diosmectite Revenue by Application
5.2.1 Global Diosmectite Historical Revenue by Application (2017-2022)
5.2.2 Global Diosmectite Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diosmectite Revenue Market Share by Application (2017-2028)
5.3 Global Diosmectite Price by Application
5.3.1 Global Diosmectite Price by Application (2017-2022)
5.3.2 Global Diosmectite Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diosmectite Market Size by Type
6.1.1 North America Diosmectite Sales by Type (2017-2028)
6.1.2 North America Diosmectite Revenue by Type (2017-2028)
6.2 North America Diosmectite Market Size by Application
6.2.1 North America Diosmectite Sales by Application (2017-2028)
6.2.2 North America Diosmectite Revenue by Application (2017-2028)
6.3 North America Diosmectite Market Size by Country
6.3.1 North America Diosmectite Sales by Country (2017-2028)
6.3.2 North America Diosmectite Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Diosmectite Market Size by Type
7.1.1 Europe Diosmectite Sales by Type (2017-2028)
7.1.2 Europe Diosmectite Revenue by Type (2017-2028)
7.2 Europe Diosmectite Market Size by Application
7.2.1 Europe Diosmectite Sales by Application (2017-2028)
7.2.2 Europe Diosmectite Revenue by Application (2017-2028)
7.3 Europe Diosmectite Market Size by Country
7.3.1 Europe Diosmectite Sales by Country (2017-2028)
7.3.2 Europe Diosmectite Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diosmectite Market Size by Type
8.1.1 Asia Pacific Diosmectite Sales by Type (2017-2028)
8.1.2 Asia Pacific Diosmectite Revenue by Type (2017-2028)
8.2 Asia Pacific Diosmectite Market Size by Application
8.2.1 Asia Pacific Diosmectite Sales by Application (2017-2028)
8.2.2 Asia Pacific Diosmectite Revenue by Application (2017-2028)
8.3 Asia Pacific Diosmectite Market Size by Region
8.3.1 Asia Pacific Diosmectite Sales by Region (2017-2028)
8.3.2 Asia Pacific Diosmectite Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Diosmectite Market Size by Type
9.1.1 Latin America Diosmectite Sales by Type (2017-2028)
9.1.2 Latin America Diosmectite Revenue by Type (2017-2028)
9.2 Latin America Diosmectite Market Size by Application
9.2.1 Latin America Diosmectite Sales by Application (2017-2028)
9.2.2 Latin America Diosmectite Revenue by Application (2017-2028)
9.3 Latin America Diosmectite Market Size by Country
9.3.1 Latin America Diosmectite Sales by Country (2017-2028)
9.3.2 Latin America Diosmectite Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diosmectite Market Size by Type
10.1.1 Middle East and Africa Diosmectite Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diosmectite Revenue by Type (2017-2028)
10.2 Middle East and Africa Diosmectite Market Size by Application
10.2.1 Middle East and Africa Diosmectite Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diosmectite Revenue by Application (2017-2028)
10.3 Middle East and Africa Diosmectite Market Size by Country
10.3.1 Middle East and Africa Diosmectite Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diosmectite Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Simcere
11.1.1 Simcere Corporation Information
11.1.2 Simcere Overview
11.1.3 Simcere Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Simcere Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Simcere Recent Developments
11.2 Ipson
11.2.1 Ipson Corporation Information
11.2.2 Ipson Overview
11.2.3 Ipson Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ipson Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ipson Recent Developments
11.3 Yangtze River Pharmaceutical Group
11.3.1 Yangtze River Pharmaceutical Group Corporation Information
11.3.2 Yangtze River Pharmaceutical Group Overview
11.3.3 Yangtze River Pharmaceutical Group Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Yangtze River Pharmaceutical Group Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Yangtze River Pharmaceutical Group Recent Developments
11.4 Shangdong Hongjitang Pharmaceutical
11.4.1 Shangdong Hongjitang Pharmaceutical Corporation Information
11.4.2 Shangdong Hongjitang Pharmaceutical Overview
11.4.3 Shangdong Hongjitang Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shangdong Hongjitang Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shangdong Hongjitang Pharmaceutical Recent Developments
11.5 Conba Pharmaceutical
11.5.1 Conba Pharmaceutical Corporation Information
11.5.2 Conba Pharmaceutical Overview
11.5.3 Conba Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Conba Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Conba Pharmaceutical Recent Developments
11.6 Harbin Pharmaceutical Group
11.6.1 Harbin Pharmaceutical Group Corporation Information
11.6.2 Harbin Pharmaceutical Group Overview
11.6.3 Harbin Pharmaceutical Group Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Harbin Pharmaceutical Group Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Harbin Pharmaceutical Group Recent Developments
11.7 Luye Pharma Group
11.7.1 Luye Pharma Group Corporation Information
11.7.2 Luye Pharma Group Overview
11.7.3 Luye Pharma Group Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Luye Pharma Group Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Luye Pharma Group Recent Developments
11.8 ZhuZhou QianJin Pharmaceutical
11.8.1 ZhuZhou QianJin Pharmaceutical Corporation Information
11.8.2 ZhuZhou QianJin Pharmaceutical Overview
11.8.3 ZhuZhou QianJin Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 ZhuZhou QianJin Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ZhuZhou QianJin Pharmaceutical Recent Developments
11.9 Zhejiang Hailisheng Pharmaceutical
11.9.1 Zhejiang Hailisheng Pharmaceutical Corporation Information
11.9.2 Zhejiang Hailisheng Pharmaceutical Overview
11.9.3 Zhejiang Hailisheng Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zhejiang Hailisheng Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zhejiang Hailisheng Pharmaceutical Recent Developments
11.10 Hanmi Pharmaceutical
11.10.1 Hanmi Pharmaceutical Corporation Information
11.10.2 Hanmi Pharmaceutical Overview
11.10.3 Hanmi Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hanmi Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hanmi Pharmaceutical Recent Developments
11.11 Lukang Pharmaceutical
11.11.1 Lukang Pharmaceutical Corporation Information
11.11.2 Lukang Pharmaceutical Overview
11.11.3 Lukang Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lukang Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lukang Pharmaceutical Recent Developments
11.12 China Resources Double-crane Pharmaceutical
11.12.1 China Resources Double-crane Pharmaceutical Corporation Information
11.12.2 China Resources Double-crane Pharmaceutical Overview
11.12.3 China Resources Double-crane Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 China Resources Double-crane Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 China Resources Double-crane Pharmaceutical Recent Developments
11.13 Honz Pharmaceutical
11.13.1 Honz Pharmaceutical Corporation Information
11.13.2 Honz Pharmaceutical Overview
11.13.3 Honz Pharmaceutical Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Honz Pharmaceutical Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Honz Pharmaceutical Recent Developments
11.14 Siromed
11.14.1 Siromed Corporation Information
11.14.2 Siromed Overview
11.14.3 Siromed Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Siromed Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Siromed Recent Developments
11.15 Salvat
11.15.1 Salvat Corporation Information
11.15.2 Salvat Overview
11.15.3 Salvat Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Salvat Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Salvat Recent Developments
11.16 Bliss GVS Pharma
11.16.1 Bliss GVS Pharma Corporation Information
11.16.2 Bliss GVS Pharma Overview
11.16.3 Bliss GVS Pharma Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Bliss GVS Pharma Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bliss GVS Pharma Recent Developments
11.17 Weiao Pharmaceuticals
11.17.1 Weiao Pharmaceuticals Corporation Information
11.17.2 Weiao Pharmaceuticals Overview
11.17.3 Weiao Pharmaceuticals Diosmectite Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Weiao Pharmaceuticals Diosmectite Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Weiao Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diosmectite Industry Chain Analysis
12.2 Diosmectite Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diosmectite Production Mode & Process
12.4 Diosmectite Sales and Marketing
12.4.1 Diosmectite Sales Channels
12.4.2 Diosmectite Distributors
12.5 Diosmectite Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diosmectite Industry Trends
13.2 Diosmectite Market Drivers
13.3 Diosmectite Market Challenges
13.4 Diosmectite Market Restraints
14 Key Findings in The Global Diosmectite Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer